How could biomarkers of ARDS and AKI drive clinical strategies?

The article reports on the potential of acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) biomarkers in enhancing clinical strategies. It mentions that both diseases induce admission to intensive care units (ICU) with significant inference towards the mortality and morbidity of patients as well as utilization of health resources. An overview of its usefulness is also presented.